RESUMEN
OBJECTIVE: Finland is one of the few countries that has established a national Medicines Information (MI) Strategy. The ultimate goal of the strategy is a well-implemented medication use process resulting in well-informed adherent patients. This study aimed at evaluating the implementation of the strategy 3 years after its launch. DESIGN: The evaluation applied a pragmatic approach and was conducted by interviewing stakeholders involved in the National MI Network enhancing the MI Strategy's implementation. The network comprises national key stakeholders producing and using MI. Data were deductively analysed according to the medication use process of the MI Strategy using the framework method, complemented with inductively derived categories. SETTING: National implementation of the MI Strategy throughout the healthcare system after the first operational period (2012-2014) in 2015. PARTICIPANTS: The members of the National MI Network (n=79/111, participation rate 71%, representing 42/53 stakeholder organisations). OUTCOME MEASURES: A new conceptual framework was developed based on stakeholders' views on well-implemented actions and actions needing development in the medication use process at (1) infrastructure (macro), (2) healthcare professionals (meso) and (3) patient (micro) levels. RESULTS: Medication counselling by community pharmacists was the primary implemented action, followed by physicians' actions while starting a new medication, and advice given by nurses. The major development needs concerned (1) poor access to patient information and its transfer in healthcare, particularly the lack of reconciled medication lists and electronic health records (macro); (2) poorly functioning medication use process in home care and social care units, such as nursing homes (meso); and (3) limited patient involvement in their care (micro). CONCLUSIONS: Far more actions for development than well-established practices in the medication use process were identified. Major challenges found in this evaluation are considered in the ongoing Rational Pharmacotherapy Action Plan 2018-2022 by the Ministry of Social Affairs and Health.
Asunto(s)
Consejo , Servicios de Información sobre Medicamentos , Cumplimiento de la Medicación , Acceso a la Información , Estudios Transversales , Femenino , Finlandia , Humanos , Masculino , Conciliación de Medicamentos , Enfermeras y Enfermeros , Farmacéuticos , Participación de los InteresadosRESUMEN
OBJECTIVE: The aim of this study was to examine long-term trends in the receipt of medicines information (MI) among adult medicine users from 1999 to 2014. DESIGN: Repeated cross-sectional postal survey from the years 1999, 2002, 2005 and 2008-2014. SETTING: Each study year, a new nationally representative sample of 5000 Finns aged 15-64 years was drawn from the Population Register Centre of Finland. PARTICIPANTS: The range of annual respondents varied from 2545 to 3371 and response rates from 53% to 67%. Of the total responses (n=29 465), 64% were from medicine users (n=18 862, ranging by year from 58% to 68%). OUTCOME MEASURES: Receipt of information on medicines in use within 12 months prior to the survey from a given list of consumer MI sources available in Finland. RESULTS: Physicians, community pharmacists and package leaflets were the most common MI sources throughout the study period. Receipt of MI increased most from the Internet (from 1% in 1999 to 16% in 2014), while decreased most from physicians (62% to 47%) and package leaflets (44% to 34%), and remained stable from community pharmacists (46% to 45%) and nurses (14% to 14%). In 1999, of the medicine users 4% did not report receipt of MI from any of the sources listed in the survey, while this proportion had remarkably increased to 28% in 2014. CONCLUSIONS: Healthcare professionals and package leaflets had still a dominating importance in 2014 despite the growing number of MI sources over time, but still a minority of adult medicine users reported receiving MI via the Internet in 2014. Worrying is that the proportion of adult medicine users who did not receive MI from any of the sources became seven fold during the study period.
Asunto(s)
Servicios de Información sobre Medicamentos/tendencias , Etiquetado de Medicamentos/tendencias , Personal de Salud , Necesidades y Demandas de Servicios de Salud/tendencias , Difusión de la Información/métodos , Folletos , Adolescente , Adulto , Estudios Transversales , Servicios de Información sobre Medicamentos/estadística & datos numéricos , Femenino , Finlandia , Humanos , Internet , Modelos Logísticos , Masculino , Persona de Mediana Edad , Farmacéuticos/estadística & datos numéricos , Médicos/estadística & datos numéricos , Vigilancia de la Población , Encuestas y Cuestionarios , Adulto JovenRESUMEN
BACKGROUND: The Finnish Medicines Agency Fimea published the first National Medicines Information (MI) strategy in 2012. For the purpose of implementing the MI strategy into practice by the national MI Network, a comprehensive inventory of MI research in Finland was needed. OBJECTIVE: To systematically review literature on MI research conducted in Finland by analyzing and classifying the studies, and identifying the gaps in MI research. METHODS: Medline, Scopus and Medic databases were searched for peer-reviewed MI publications by using key word screening criteria. The search and extraction process followed PRISMA Guidelines and covered the period from January 2000 to June 2016. Included studies were content analyzed according to MI practices identified, trends over time in research methodology and theory. RESULTS: Included publications (nâ¯=â¯126) applied a variety of research methods, most often cross-sectional surveys (nâ¯=â¯51, 40% of all studies), but more than half of the studies were qualitative (nâ¯=â¯68, 54%). Twelve were intervention studies of which 6 were randomized and had a control group. Studies were categorized into: patient counseling in different settings (nâ¯=â¯45); MI sources and needs of medicine users (nâ¯=â¯25); healthcare professionals' (HCPs) competence in patient counseling and pharmacotherapy (nâ¯=â¯25); MI sources and needs of HCPs (nâ¯=â¯23); MI education and literacy (nâ¯=â¯13); and MI policies and strategies (nâ¯=â¯3). Most of the studies were descriptive, and only 6 studies applied a theory. CONCLUSIONS: Regardless of some methodological pitfalls, MI research conducted in Finland since 2000 provides multifaceted understanding of MI practices and their development needs. Research should shift towards larger research lines having a stronger theory base and study designs to deepen the understanding of MI practices and behaviors, and effectiveness of MI in different healthcare settings. Future research should cover also the use of electronic MI sources and services which apply modern information technology to clinical decision making and medication reviews, national MI policy, MI literacy, MI needs of HCPs and consumers.